Bausch Health Companies Inc (BHC)

[Paullee]

BHC: Xifaxan IP outcome highly important, possible ripple
“Sometime in August”, BHC expects Judge Andrews to issue a ruling in the Xifaxan
patent dispute (vs. Alvogen-Norwich). Based on the trial, the primary patents-in-dispute
are BHC’s method-of-use patents (Alvogen stipulated infringement of polymorph
patent), which puts the risk of LOE (currently Jan. 1, 2028) possibly earlier, sometime in
2H’24E. Sizing the stock upside is challenging, given the bulk of the SOTP value resides
in a future (planned) spin-off (or distribution) of BLCO shares to BHC holders. At a
minimum, a clear win across all patents-in-dispute would narrow the ~25% discount
(market cap of BHC vs. BLCO) on the 80% of BLCO value that BHC shareholders are
expected to receive, while additional upside depends on whether BLCO actually trades at
a discount due to the Xifaxan outcome (and presumed risk it poses to a clean
distribution). Risk to the downside – similarly unclear given Bausch could still appeal the
ruling and look to execute a spin-off (even following a patent loss scenario) per prior
BHC Chairman Joe Papa. BHC now trades at 7.7x 2022E EBITDA vs. 6-7.6x for spec
pharma peers, thus we see de-rating as a risk in a patent loss scenario with CF durability
(LOE overhang) issues. We maintain Underperform on BHC as we are more cautious on
SOTP value-unlock thesis and risks to protracted time-to-spin.

[conix]

I agree that this stability in this market is a good sign. Still have a small position...but will look to get more once things start to settle down.

[Porterhouse10]

Trading sideways now through the volatility, might be a good sign $BHC

[conix]

Bought some BHC this morning.

Too tempting

[conix]

Bausch + Lomb Launches IPO and Begins Trading Under "BLCO" Ticker; Bausch Health Will Separate Chairman and CEO Roles

Bausch Health's eye health business, Bausch + Lomb, which launched its initial public offering ("IPO") and subsequently began trading under the ticker "BLCO" on May 6, 2022, expects the IPO to close today, May 10, 2022. Bausch + Lomb remains on track to spin off from Bausch Health, following the expiry of customary lock-ups related to the IPO, achievement of target net leverage ratios and subject to market conditions, receipt of applicable shareholder and other necessary approvals.2 The Company expects to close the IPO with $630 million in gross proceeds to be applied for the repayment of Bausch Health's long-term debt on May 10, 2022.

Mr. Appio will assume the role of CEO of Bausch Health, effective upon the closing of the IPO of Bausch + Lomb. The Company also separated the roles of chairman and CEO, with Joseph C. Papa remaining as Chairman until the full separation of Bausch + Lomb. Mr. Papa will be succeeded by Robert N. Power.4

[Porterhouse10]

Dude wtf, wow

[conix]

VERY rare to see an RSI at 12 and not see a big gain within three months.

[Porterhouse10]

RSI @12.55, Holy Crap talk about Oversold

[Porterhouse10]

Markets are wild, dont know much about this one but the Puts bought and Sold today after Cramer said he wanted some, although this seems oversold

[conix]

Agreed. There are some stocks out here, like BHC, which are getting oversold--but the overall market is NOT oversold yet. So the risk is still there that these oversold stocks still go down some more.

I have put in a BUY order at the double bottom price--for an initial position.

[Atlanta1]

looks like an amazing buy. total overreaction by the market.

[conix]

Double Bottom coming?

[Zilla]

Have to go up 50% to reach where we were a month ago. Should have just cancelled the IPO

[Porterhouse10]

Cramer says he wants to buy for his Travel Trust, guess I'll buy Puts

[Zilla]

Hit a low of 18.20 with IPO not being as big (10%) and the range (21-24) being too low for big debt payoff. Oh well...At least we will get to look at B&L as a separate company.

[Zilla]

Looks like 18 may happen if no IPO soon and 14 had a lot of action looking at your chart if it is officially postponed. Timing is EVERYTHING and IPO window isn't looking good with overall market and current PPS of BHC.

[judypudy]

Agree. IMO PAPA should go ahead and bring the IPO to market as soon as possible.

[Atlanta1]

low $20's now - looks cheap based on earnings estimates as well as the upcoming spinoff IPO's

$BHC

[mdb1]

Such high hopes but fizzled in the mid/upper $30s. I thought it could go to the $80s.

[conix]

CHART

[conix]

Watching BHC going into the end of the year

[mdb1]

Still it hit $34.80 before dropping some and that ain't bad.

[Monika75]

Oops! It looks like l was wrong!

[Monika75]

Easy 40$ this month!

[mdb1]

Hit $34s today and hitting 52 week highs almost EVERY day

[mdb1]

Hit $33+ this morning.

[Monika75]

By the end of March 40$!

[mdb1]

Carl Ichan .. Carl Ichan .. Carl Ichan

[Monika75]

For the very first time in years l am very positive about BHC!

[mdb1]

It's been years since BHC has hit $32s. YEARS.

[Monika75]

I am confident it is coming !!!!!

[mdb1]

BHC showing strength -Carl Ichan ..Carl Ichan .. Carl Ichan
But we need help from US markets to reach $40 in March.

Carl took Apple from $388 to high $700s in 3 months.

[Monika75]

I see very clearly 40$ coming soon!

[conix]

CHART of BHC

[mdb1]

Maybe in 6 months. But it depends on the stock market continuing to go UP

[Monika75]

What do you think? How kind ll take to get to 50ties?

[mdb1]

BHC imo could hit $50s: Carl Icahn disclosed a 7.8% stake in BHC and is now largest single shareholder.

[Monika75]

Mdb1, l cannot even express my happiness l have been waiting for this moment years!!!!

[mdb1]

Monika I think it could hit $40s by March!!!!!!!!!!!!!

[mdb1]

$32.40s and 4th 52-week high

[mdb1]

New 52week high 3rd day in row.

[conix]

Bausch Health (BHC): Bausch Health jumped 6.3% premarket following news that billionaire investor Carl Icahn has taken a 7.8% stake, according to a Securities and Exchange Commission filing. Icahn plans to give input on the pharmaceutical company’s strategies and possibly seek board representation.

[conix]

BHC After Hours: Last | 02/11/21 EST
32.00
quote price arrow up+1.89 (+6.28%)
Volume
1,890,960

[mdb1]

Thanks!

[north40000]

Carl Icahn took a position in BHC, and intends to talk with management.

CNBC-TV report

[mdb1]

It's $33.70 in after hours trading with way over a million shares trading!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

[Monika75]

Mdb1, l have been waiting for this moment for while! I cannot wait to see BHC in 40ties! They really deserved some recognition !

[mdb1]

I think it's going into the $30s Monika

[mdb1]

Hit 52 week HIGHs 2 days in a row

[Monika75]

Finally!!!!